Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEX-ESK Combination for Chronic Postsurgical Pain After Spinal Surgery
NCT07525999Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Apr 2026
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and esketamine in chronic postsurgical pain (CPSP) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Incidence of chronic pain at 3 months. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
dexmedetomidineesketamine
03
Conditions
chronic postsurgical pain (CPSP)
Beyond the preview
Go deeper on NCT07525999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07525999.